Clinical Trial Update: A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating LY3537021 for chemotherapy-induced nausea and vomiting in adults with cancer; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• LY3537021 (LY3537021)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Nausea, Vomiting | Phase 2 | Status: RECRUITING